Teijin Limited (JP:3401)
:3401
Top Page
Teijin
(3401)
Select Model
Select Model
Rating:53Neutral
Price Target:
¥1,601.00
▲(18.86% Upside)
Action:ReiteratedDate:02/06/26
The score is held back primarily by weak financial performance, with TTM losses and negative returns despite some support from positive free cash flow. Technicals provide a meaningful offset given a strong uptrend, but overbought signals temper the technical score. Valuation is mixed: an acceptable dividend yield is outweighed by a negative P/E tied to current losses.
Positive Factors
Diversified Business Model
Teijin's dual focus on advanced materials and healthcare provides structural resilience. Materials address durable industrial end markets (automotive, composites) while healthcare supplies recurring revenue streams and services. This mix reduces dependence on any single cycle and supports long-term cash generation and client relationships.
Negative Factors
Operating and Net Losses
Material operating and net losses are a structural concern: they erode retained earnings, limit reinvestment capacity, and can force cost cuts that harm long-term competitiveness. Persistent negative margins also undermine stakeholder confidence and constrain strategic flexibility over the next several quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified Business Model
Teijin's dual focus on advanced materials and healthcare provides structural resilience. Materials address durable industrial end markets (automotive, composites) while healthcare supplies recurring revenue streams and services. This mix reduces dependence on any single cycle and supports long-term cash generation and client relationships.
Read all positive factors
Teijin (3401) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥326.84B
Dividend Yield3.72%
Average Volume (3M)1.23M
Price to Earnings (P/E)―
Beta (1Y)0.82
Revenue Growth-8.20%
EPS GrowthN/A
CountryJP
Employees21,834
SectorIndustrials
Sector Strength72
IndustryConglomerates
Share Statistics
EPS (TTM)-21.40
Shares Outstanding197,953,700
10 Day Avg. Volume898,600
30 Day Avg. Volume1,234,116
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)0.59
Price to Sales (P/S)0.25
P/FCF Ratio20.28
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥1,437.50Price Target Upside6.72% Upside
Rating ConsensusHold
Number of Analyst Covering4
EPS Forecast (FY)83.22
Revenue Forecast (FY)¥872.36B
Teijin Business Overview & Revenue Model
Company Description
Teijin Limited engages in the fibers, films and sheets, composites, healthcare, and IT businesses worldwide. It offers aramid fibers and polyethylene materials; carbon fibers, composite materials, and oxidized PAN fibers; polycarbonate sheets and ...
How the Company Makes Money
Teijin generates revenue through several key streams, primarily from the sale of high-performance materials, including aramid and carbon fibers, which are critical in industries such as automotive and aerospace. The company also earns income from ...
Teijin Earnings Call Summary
Earnings Call Date:Feb 06, 2025
(Q3-2024)
| % Change Since: |
Next Earnings Date:May 11, 2026
Earnings Call Sentiment Neutral
The earnings call highlighted a positive turnaround in net income and an improved operating income forecast. However, significant challenges remain in the Materials and Healthcare segments, with operational issues in the Composites and Aramid businesses. The company faces external pressures from strikes and generic competition but is taking steps to improve profitability.Positive Updates
Positive Net Income Turnaround
Net income was JPY 3.5 billion, turning black from the previous year's loss.
Negative Updates
Materials Business Loss
The materials business remains at an operating income level of negative JPY 5.8 billion.
Read all updates
Q3-2024 Updates
Positive
Negative
Positive Net Income Turnaround
Net income was JPY 3.5 billion, turning black from the previous year's loss.
Read all positive updates
Company Guidance
In the earnings call for the third quarter of 2024, company executives Eiji Ogawa and Akimoto Uchikawa provided a detailed analysis of financial performance and strategic initiatives. For the first nine months of the fiscal year, net sales remained steady at JPY 759.6 billion, while operating income fell by JPY 10 billion to JPY 4.9 billion, mainly due to a one-off contract fee. The company's net income turned positive at JPY 3.5 billion, reversing last year's loss. The full-year forecast predicts net sales of JPY 1,030 billion and operating income of JPY 18 billion, which is a 40% increase from the previous year but JPY 17 billion below the earlier forecast. Uchikawa discussed the profitability improvement measures, with a focus on underperforming sectors like Composites and Healthcare, aiming for JPY 19 billion in profit improvements. Despite challenges like the UAW strike and equipment failures in North America, some segments, such as Fibers & Products, showed robust performance with a JPY 1.4 billion increase in operating income to JPY 9.3 billion. The Healthcare business, however, saw a JPY 19.2 billion drop in operating profit, influenced by the entry of a generic competitor to their main drug. The executives also highlighted ongoing efforts to stabilize gas prices and improve productivity, with a strategic focus on addressing low ROE and enhancing shareholder value.Teijin Financial Statement Overview
Summary
Income Statement
34
Negative
Balance Sheet
48
Neutral
Cash Flow
62
Positive
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 909.24B | 1.01T | 960.46B | 1.02T | 926.05B | 836.51B |
| Gross Profit | 170.53B | 191.45B | 210.64B | 218.76B | 241.27B | 241.33B |
| EBITDA | -15.00B | -7.85B | 64.01B | 91.63B | 113.02B | 106.77B |
| Net Income | -81.60B | 28.35B | -11.71B | -17.70B | 23.16B | -6.66B |
Balance Sheet | ||||||
| Total Assets | 989.64B | 1.06T | 1.23T | 1.27T | 1.24T | 1.07T |
| Cash, Cash Equivalents and Short-Term Investments | 122.17B | 107.54B | 123.21B | 142.78B | 134.48B | 170.19B |
| Total Debt | 388.34B | 387.13B | 516.94B | 536.23B | 485.17B | 380.04B |
| Total Liabilities | 598.45B | 622.73B | 789.86B | 821.37B | 774.20B | 643.95B |
| Stockholders Equity | 387.05B | 431.38B | 409.51B | 425.66B | 440.38B | 407.05B |
Cash Flow | ||||||
| Free Cash Flow | 42.66B | 12.45B | 22.48B | 3.57B | 29.06B | 50.91B |
| Operating Cash Flow | 102.19B | 69.84B | 80.59B | 55.09B | 89.66B | 107.73B |
| Investing Cash Flow | -48.73B | 52.52B | -56.56B | -52.43B | -198.38B | -79.59B |
| Financing Cash Flow | -142.77B | -134.46B | -43.79B | 7.18B | 71.11B | -20.88B |
Teijin Technical Analysis
Positive
1347.00
Price Trends
1608.05
Positive
1464.58
Positive
1349.95
Positive
Market Momentum
37.27
Negative
60.48
Neutral
77.02
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3401, the sentiment is Positive. The current price of 1347 is below the 20-day moving average (MA) of 1619.69, below the 50-day MA of 1608.05, and below the 200-day MA of 1349.95, indicating a bullish trend. The MACD of 37.27 indicates Negative momentum. The RSI at 60.48 is Neutral, neither overbought nor oversold. The STOCH value of 77.02 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3401.
Teijin Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥181.34B | 12.04 | 8.27% | 2.68% | -2.45% | 7.31% | |
75 Outperform | ¥153.07B | 9.78 | ― | 2.66% | -1.63% | 67.13% | |
73 Outperform | ¥237.16B | 9.23 | ― | 3.90% | 2.65% | 7.16% | |
71 Outperform | ¥1.08T | 16.83 | 7.53% | 3.13% | 1.90% | -6.73% | |
65 Neutral | ¥258.21B | 524.13 | 8.35% | 2.73% | 3.35% | 810.44% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
53 Neutral | ¥326.84B | -15.81 | -20.43% | 3.72% | -8.20% | ― |
* Industrials Sector Average
JP:3401
Teijin
1,650.50
538.63
48.44%
JP:3105
Nisshinbo Holdings
1,666.00
879.88
111.93%
JP:4204
Sekisui Chemical Co
2,643.50
298.39
12.72%
JP:5331
Noritake Co.,Limited
3,235.00
1,559.51
93.08%
JP:3106
KURABO INDUSTRIES LTD.
9,920.00
4,430.25
80.70%
JP:4206
Aica Kogyo Company, Limited
3,577.00
445.85
14.24%
Teijin Corporate Events
Teijin Holds Earnings Outlook Despite 3Q Slump
Feb 4, 2026
Third-quarter FY2025 adjusted operating income fell ¥1.8 billion year-on-year to ¥23.8 billion as maintenance downtime, weaker materials mix, and the removal of aramid paper profits outweighed healthcare gains, with impairment charges ti...
Teijin Swings to Nine-Month Loss but Keeps Dividend and Full-Year Guidance Intact
Feb 4, 2026
Teijin reported a sharp deterioration in results for the nine months to December 31, 2025, with revenue down 12.7% year on year to ¥659.9 billion and adjusted operating income slipping 7.0% to ¥23.8 billion, while operating income and pr...
Teijin Announces Merger with Asahi Kasei Advance to Boost Textile Business
Dec 1, 2025
Teijin Limited has announced a definitive agreement for a business integration between its subsidiary, Teijin Frontier, and Asahi Kasei Advance Corporation, a subsidiary of Asahi Kasei. This merger aims to enhance competitiveness by combining stre...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.